Inhibitors of (α-v)(β-6) integrin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11827621
APP PUB NO 20210276975A1
SERIAL NO

17314777

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are small molecule inhibitors of αvβ6 integrin, and methods of using them to treat a number of diseases and conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MORPHIC THERAPEUTIC, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brewer, Mark Wallingford, GB 14 98
Bursavich, Matthew G Needham, US 21 101
Gerasyuto, Aleksey I Flemington, US 30 109
Hahn, Kristopher N Medford, US 16 81
Harrison, Bryce A Framingham, US 21 84
Konze, Kyle D Brooklyn, US 19 81
Lin, Fu-Yang Sudbury, US 19 84
Lippa, Blaise S Newton, US 28 193
Lugovskoy, Alexey A Belmont, US 31 213
Rogers, Bruce N Belmont, US 40 489
Svensson, Mats A New York, US 19 80
Troast, Dawn M Bedford, US 19 84

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 28, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 May 28, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 28, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00